• Find a pharmacy

Get caught up without having to flip through your calendar

While other adult hepatitis B vaccines require at least 3 doses and take 6 months to complete, HEPLISAV-B offers protection with just 2 doses over 1 month.

Save time by opting for fewer doses

GETTING PROTECTED

Parents know a thing or two about follow-through, and when it comes to hepatitis B vaccination, completing all doses is essential for protection.

What do your next 6 months look like?

Family life gets full, fast. Knocking out 2 doses over 1 month with HEPLISAV-B gets you caught up sooner, so you’re not stuck trying to plan for an additional dose 6 months down the line.

Effective hepatitis B protection

Better PROTECTION
HEPLISAV-B had significantly faster and higher rates of protection compared to a 3-dose hepatitis B vaccine in 3 separate clinical trials.
SAFETY
HEPLISAV-B was well tolerated in clinical trials of over 10,000 patients. (That’s the largest safety database for any hepatitis B vaccine!)
Smiling dad gives daughter a piggy-back ride

Getting vaccinated can be simple

Of course you made sure your child was protected against hepatitis B. Now there’s an easy way for you to catch up on your own health, with HEPLISAV-B. 2 doses. 1 month. Done.
Find out how
Based on a 2018 study of 10,888 adults who began hepatitis B vaccination series with either 2-dose HEPLISAV-B or 3-dose Engerix-B.
INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see full Prescribing Information.

INDICATION & Important Safety Information

INDICATION

HEPLISAV-B is indicated for the prevention of infection caused by the hepatitis B virus in adults 18 years of age and older.

IMPORTANT SAFETY INFORMATION

If you have a history of severe allergic reaction after a previous dose of any hepatitis B vaccine, or to any ingredient of HEPLISAV-B, including yeast, do not take HEPLISAV-B.

HEPLISAV-B must be given by a medical professional, who will monitor you afterwards to check for allergic reaction.

If you are immunocompromised, or receiving immunosuppressant therapy, you may have less of an immune response to HEPLISAV-B.

Some people have hepatitis B infection without being aware of it or showing any symptoms. If you already have hepatitis B present in your body, HEPLISAV-B may not prevent hepatitis B infection.

The most common side effects reported by patients within 7 days of vaccination with HEPLISAV-B were pain at the site of injection (23%-39%), tiredness (11%-17%), and headache (8%-17%).

Please see full Prescribing Information.

This website is intended for US audiences only.